Myelofibrosis Secondary to Hyperparathyroidism

Abstract

We report on a young female who had presented with fatigue, bilateral knee pain and gait disturbance. Primary hyperparathyroidism was diagnosed together with splenomegaly and anemia. Bone marrow biopsy revealed myelofibrosis. A parathyroid adenoma was excised during surgical intervention. As early as three months after the operation, hematologic parameters improved along with bone markers without any other intervention. The control bone marrow biopsy demonstrated well marked regression in marrow fibrosis. Her spleen has also gradually decreased in size.

These findings indicate that her myelofibrosis was the result of primary hyperparathyroidism. Anemia associated with primary hyperparathyroidism may be due to bone marrow fibrosis.

Hyperparathyroidism - myelofibrosis - anemia

References

• 1 Abarca J, Trigonis C, Hamberger B, Granberg P O. Anaemia in primary hyperparathyroidism - fantasy or reality.  Ann Chir Gynaecol. 1985;  74 74-76
• 2 Abdelhadi M, Nordenström J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.  J Clin Endocrinol Metab. 1998;  83 3845-3851
• 3 Athens J W. Myelofibrosis. Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN Wintrobe's Clinical Hematology. 9th ed. Philadelphia; Lea & Febige 1993: 2018-2033
• 4 Bilezikian J P. Primary hyperparathyroidism: when to observe and when to operate.  Endocrin Metab Clin North Am. 2000;  29 465-477
• 5 Boxer M, Ellman L, Geller R, Wang C A. Anemia in primary hyperparathyroidism.  Arch Intern Med. 1977;  137 588-590
• 6 Bringhurst F R, Demay M B, Kronenberg H M. Hormones and disorders of mineral metabolism. Wilson JD, Foster DW, Kronenberg HM, Larsen PD Williams Textbook of Endocrinology. 9th ed. Philadelphia; WB Saunders Company 1998: 1155-1209
• 7 Bruder J M, Guise T A, Mundy G R. Mineral metabolism. Felig P, Frohman LA Endocrinology & Metabolism. 4th ed. New York; McGraw-Hill Inc 2001: 1079-1177
• 8 Deaconson T F, Wilson S D, Lemann J. The effect of parathyroidectomy on the recurrence of nephrolithiasis.  Surgery. 1987;  102 910-913
• 9 Duarte M E, Carvalho E F, Cruz E A, Lucena S B, Andress D L. Cytokine accumulation in osteitis fibrosa of renal osteodystrophy.  Braz J Med Biol Res. 2002;  35 25-29
• 10 Eigelberger M S, Clark O H. Surgical approaches to primary hyperparathyroidism.  Endocrinol Metab Clin North Am. 2000;  29 479-502
• 11 Erslev A J. Anemia of chronic disease. Beutler E, Lichtman MA, Coller BS, Kipps TJ, Selighson U Williams Hematology. 6th ed. New York; McGraw-Hill Inc 2001: 481-487
• 12 Falko J M, Guy J T, Smith R E, Mazzaferri E L. Primary hyperparathyroidism and anemia.  Arch Intern Med. 1976;  136 887-889
• 13 Grey A, Mitnick M A, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - a clinical research center study.  J Clin Endocrinol Metab. 1996;  81 3450-3454
• 14 Irvin G L, Newell D J, Morgan S D. Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.  Surgery. 1987;  102 898-902
• 15 Kotzmann H, Abela C, Heindl J, Clodi M, Riedl M, Barnas U, Heinzl H, Niederle B, Geissler K, Waldhausl W, Luger A. Effect of successful parathyroidectomy on hematopoietic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidism.  Horm Metab Res. 1997;  29 387-392
• 16 Lindenbaum J. An approach to the anemias. Bennet JC, Plum F Cecil Textbook of Medicine. 20th ed. Philadelphia; Saunders Company 1996: 823-831
• 17 Mallette L E. Anemia in hypercalcemic hyperparathyroidism.  Arch Intern Med. 1977;  137 572-573
• 18 Massry S G. Parathyroid hormone as a uremic toxin. Massry SG, Glassock RJ Massry and Glassock's Textbook of Nephrology. 3rd ed. Baltimore; Williams & Wilkin 1995: 1270-1303
• 19 Meytes D, Bogin E, Ma A, Dukes P P, Massry S G. Effect of parathyroid hormone on erythropoiesis.  J Clin Invest. 1981;  67 1263-1269
• 20 National Institutes of Health . Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement.  Ann Intern Med. 1991;  114 593-597
• 21 Nomura S, Ogawa Y, Osawa G, Katagiri M, Harada T, Nagahana H. Myelofibrosis secondary to renal osteodystrophy.  Nephron. 1996;  72 683-687
• 22 Potts J T. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. Fauci AS, Braunwald E, Isselbacher KJ, Wilson J, Martin JB, Kasper DL, Hauser SL, Longo DL Harrison's Principles of Internal Medicine. 14th ed. New York; McGraw-Hill Inc 1998: 2227-2247
• 23 Rao D S, Shih M S, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.  N Engl J Med. 1993;  328 171-175
• 24 Silverberg S J, Locker F G, Bilezikian J P. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.  J Clin Endocrinol Metab. 1996;  81 4007-4012
• 25 Silverberg S J, Gartenberg F, Jacobs T P, Shane E, Siris E, Staron R B, McMahon D J, Bilezikian J P. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.  J Clin Endocrinol Metab. 1995;  80 729-734
• 26 Spiegel A M. The parathyroid glands, hypercalcemia, and hypocalcemia. Bennet JC, Plum F Cecil Textbook of Medicine. 20th ed. Philadelphia; Saunders Company 1996: 1365-1373
• 27 Strewler G J. Medical approaches to primary hyperparathyroidism.  Endocrinol Metab Clin North Am. 2000;  29 523-539
• 28 Turken S A, Cafferty M, Silverberg S J, De La Cruz L, Cimino C, Lange D J, Lovelace R E, Bilezikian J P. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism.  Am J Med. 1989;  87 553-557
• 29 Urena P, Eckardt K U, Sarfati E, Zingraff J, Zins B, Roullet J B, Roland E, Drueke T, Kurtz A. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy.  Nephron. 1991;  59 384-393
• 30 Zingraff J, Drüeke T, Marie P, Man N K, Jungers P, Bordier P. Anemia and secondary hyperparathyroidism.  Arch Intern Med. 1978;  138 1650-1652